MMED growth lifts as new launches target Type 2 expansion
MMED says U.S. growth accelerated in Q1 on new product launches, including Fit patch pump and a Vivera algorithm aimed at expanding the Type 2 market. Manufacturing and pharmacy strategies support upcoming launches; international growth remains robust.
S. growth accelerated in Q1 on new product launches, with the Fit patch pump and Vivera algorithm expected to expand the market, especially among Type 2 patients. Manufacturing and pharmacy plans are in place to support upcoming launches, while international growth remains robust. Guidance and pr…